Clinical trial
A Phase I Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer
NCT05420519 is registered in ClinicalTrials.gov with Chongqing Precision Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer
- Lead sponsor
- Chongqing Precision Biotech Co., Ltd
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 31, 2021
- Completion date
- December 31, 2024
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer, metastatic tumor, renal cell carcinoma